vTv Therapeutics, Inc. (VTVT)
33.89
+0.64
(+1.91%)
USD |
NASDAQ |
Aug 24, 16:00
33.61
-0.28
(-0.83%)
After-Hours: 20:00
vTv Therapeutics Total Assets (Quarterly) : 87.59M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.59M |
| March 31, 2026 | 98.81M |
| December 31, 2025 | 89.90M |
| September 30, 2025 | 99.49M |
| June 30, 2025 | 26.45M |
| March 31, 2025 | 32.03M |
| December 31, 2024 | 38.27M |
| September 30, 2024 | 43.16M |
| June 30, 2024 | 46.46M |
| March 31, 2024 | 54.18M |
| December 31, 2023 | 11.02M |
| September 30, 2023 | 14.92M |
| June 30, 2023 | 22.43M |
| March 31, 2023 | 28.83M |
| December 31, 2022 | 33.24M |
| September 30, 2022 | 39.52M |
| June 30, 2022 | 36.99M |
| March 31, 2022 | 20.18M |
| December 31, 2021 | 25.47M |
| September 30, 2021 | 31.43M |
| June 30, 2021 | 21.66M |
| March 31, 2021 | 16.75M |
| December 31, 2020 | 14.79M |
| Date | Value |
|---|---|
| September 30, 2020 | 7.046M |
| June 30, 2020 | 10.63M |
| March 31, 2020 | 7.389M |
| December 31, 2019 | 9.266M |
| September 30, 2019 | 9.122M |
| June 30, 2019 | 9.072M |
| March 31, 2019 | 10.74M |
| December 31, 2018 | 8.559M |
| September 30, 2018 | 11.09M |
| June 30, 2018 | 11.23M |
| March 31, 2018 | 14.73M |
| December 31, 2017 | 27.92M |
| September 30, 2017 | 24.06M |
| June 30, 2017 | 35.78M |
| March 31, 2017 | 48.33M |
| December 31, 2016 | 54.50M |
| September 30, 2016 | 54.72M |
| June 30, 2016 | 66.78M |
| March 31, 2016 | 79.56M |
| December 31, 2015 | 91.53M |
| September 30, 2015 | 100.20M |
| June 30, 2015 | 18.97M |
| March 31, 2015 | 115.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 1.173B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.961M |
| Shareholders Equity (Quarterly) | 78.63M |
| Current Ratio | 12.48 |
| Net Debt Paydown Yield | 0.02% |